Most employers are unaware of how pharmacy benefit managers handle the rebates from drug makers, revealing a lack of transparency in the drug pricing system.
The confusion among employers about the flow of rebate money demonstrates the opaque relationship between pharmaceutical companies and pharmacy benefit managers.
Survey data shows that while PBM leaders claim up to 98% of rebates go to employers, nearly 37% of employers are unsure about these rebates.
Gary Claxton of KFF emphasizes that the complexity of financial flows in the pharmaceutical industry hampers employers' understanding of their drug benefit management.
#pharmacy-benefit-managers #drug-rebates #employer-health-benefits #pharmaceutical-industry #healthcare-transparency
Collection
[
|
...
]